197 related articles for article (PubMed ID: 24566260)
1. Quantification of tau in cerebrospinal fluid by immunoaffinity enrichment and tandem mass spectrometry.
McAvoy T; Lassman ME; Spellman DS; Ke Z; Howell BJ; Wong O; Zhu L; Tanen M; Struyk A; Laterza OF
Clin Chem; 2014 Apr; 60(4):683-9. PubMed ID: 24566260
[TBL] [Abstract][Full Text] [Related]
2. An immuno-enrichment free, validated quantification of tau protein in human CSF by LC-MS/MS.
Self W; Awwad K; Savaryn JP; Schulz M
PLoS One; 2022; 17(6):e0269157. PubMed ID: 35653415
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
[TBL] [Abstract][Full Text] [Related]
4. Development of immunoprecipitation - two-dimensional liquid chromatography - mass spectrometry methodology as biomarker read-out to quantify phosphorylated tau in cerebrospinal fluid from Alzheimer disease patients.
Bijttebier S; Theunis C; Jahouh F; Martins DR; Verhemeldonck M; Grauwen K; Dillen L; Mercken M
J Chromatogr A; 2021 Aug; 1651():462299. PubMed ID: 34107398
[TBL] [Abstract][Full Text] [Related]
5. Mass Spectrometry-Based Quantification of Tau in Human Cerebrospinal Fluid Using a Complementary Tryptic Peptide Standard.
Zhou M; Duong DM; Johnson ECB; Dai J; Lah JJ; Levey AI; Seyfried NT
J Proteome Res; 2019 Jun; 18(6):2422-2432. PubMed ID: 30983353
[TBL] [Abstract][Full Text] [Related]
6. Quantification of Amyloid-β in Plasma by Simple and Highly Sensitive Immunoaffinity Enrichment and LC-MS/MS Assay.
Iino T; Watanabe S; Yamashita K; Tamada E; Hasegawa T; Irino Y; Iwanaga S; Harada A; Noda K; Suto K; Yoshida T
J Appl Lab Med; 2021 Jul; 6(4):834-845. PubMed ID: 33462584
[TBL] [Abstract][Full Text] [Related]
7. Immunoaffinity microflow liquid chromatography/tandem mass spectrometry for the quantitation of PD1 and PD-L1 in human tumor tissues.
Zhu Y; Zalaznick J; Sleczka B; Parrish K; Yang Z; Olah T; Shipkova P
Rapid Commun Mass Spectrom; 2020 Oct; 34(20):e8896. PubMed ID: 32666620
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Neuron-Specific enolase isozymes in human serum using immunoaffinity purification and liquid chromatography-tandem mass spectrometry quantification.
Genet SAAM; Wolfs JRE; Vu CBAK; Wolter M; Broeren MAC; van Dongen J; Brunsveld L; Scharnhorst V; van de Kerkhof D
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 May; 1223():123701. PubMed ID: 37086508
[TBL] [Abstract][Full Text] [Related]
9. Online high-flow peptide immunoaffinity enrichment and nanoflow LC-MS/MS: assay development for total salivary pepsin/pepsinogen.
Neubert H; Gale J; Muirhead D
Clin Chem; 2010 Sep; 56(9):1413-23. PubMed ID: 20472821
[TBL] [Abstract][Full Text] [Related]
10. Quantification of the lung cancer tumor marker CYFRA 21-1 using protein precipitation, immunoaffinity bottom-up LC-MS/MS.
Genet SAAM; van den Wildenberg SAH; Broeren MAC; van Dongen JLJ; Brunsveld L; Scharnhorst V; van de Kerkhof D
Clin Chem Lab Med; 2024 Mar; 62(4):720-728. PubMed ID: 37886827
[TBL] [Abstract][Full Text] [Related]
11. A novel liquid chromatography/tandem mass spectrometry method for the quantification of glycine as biomarker in brain microdialysis and cerebrospinal fluid samples within 5min.
Voehringer P; Fuertig R; Ferger B
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 939():92-7. PubMed ID: 24121745
[TBL] [Abstract][Full Text] [Related]
12. Infliximab quantitation in human plasma by liquid chromatography-tandem mass spectrometry: towards a standardization of the methods?
Jourdil JF; Lebert D; Gautier-Veyret E; Lemaitre F; Bonaz B; Picard G; Tonini J; Stanke-Labesque F
Anal Bioanal Chem; 2017 Feb; 409(5):1195-1205. PubMed ID: 27826630
[TBL] [Abstract][Full Text] [Related]
13. Quantification of cardiac troponin I in human plasma by immunoaffinity enrichment and targeted mass spectrometry.
Schneck NA; Phinney KW; Lee SB; Lowenthal MS
Anal Bioanal Chem; 2018 Apr; 410(11):2805-2813. PubMed ID: 29492621
[TBL] [Abstract][Full Text] [Related]
14. A versatile method for protein-based antigen bioanalysis in non-clinical pharmacokinetics studies of a human monoclonal antibody drug by an immunoaffinity liquid chromatography-tandem mass spectrometry.
Onami I; Ayabe M; Murao N; Ishigai M
J Chromatogr A; 2014 Mar; 1334():64-71. PubMed ID: 24572547
[TBL] [Abstract][Full Text] [Related]
15. Increased throughput for low-abundance protein biomarker verification by liquid chromatography/tandem mass spectrometry.
Berna M; Ackermann B
Anal Chem; 2009 May; 81(10):3950-6. PubMed ID: 19388669
[TBL] [Abstract][Full Text] [Related]
16. Characterization of tau in cerebrospinal fluid using mass spectrometry.
Portelius E; Hansson SF; Tran AJ; Zetterberg H; Grognet P; Vanmechelen E; Höglund K; Brinkmalm G; Westman-Brinkmalm A; Nordhoff E; Blennow K; Gobom J
J Proteome Res; 2008 May; 7(5):2114-20. PubMed ID: 18351740
[TBL] [Abstract][Full Text] [Related]
17. Comparison of a stable isotope labeled (SIL) peptide and an extended SIL peptide as internal standards to track digestion variability of an unstable signature peptide during quantification of a cancer biomarker, human osteopontin, from plasma using capillary microflow LC-MS/MS.
Faria M; Halquist MS; Yuan M; Mylott W; Jenkins RG; Karnes HT
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1001():156-68. PubMed ID: 26279007
[TBL] [Abstract][Full Text] [Related]
18. Quantification of serum C-peptide by isotope-dilution liquid chromatography-tandem mass spectrometry: enhanced detection using chemical modification and immunoaffinity purification.
Kinumi T; Mizuno R; Takatsu A
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Mar; 953-954():138-42. PubMed ID: 24607695
[TBL] [Abstract][Full Text] [Related]
19. Development of a candidate reference measurement procedure by ID-LC-MS/MS for total tau protein measurement in cerebrospinal fluid (CSF).
Giangrande C; Vaneeckhoutte H; Boeuf A; Lalere B; Hirtz C; Lehmann S; Quaglia M; Delatour V
Clin Chem Lab Med; 2023 Jun; 61(7):1235-1244. PubMed ID: 36815732
[TBL] [Abstract][Full Text] [Related]
20. Sequential protein and peptide immunoaffinity capture for mass spectrometry-based quantification of total human β-nerve growth factor.
Neubert H; Muirhead D; Kabir M; Grace C; Cleton A; Arends R
Anal Chem; 2013 Feb; 85(3):1719-26. PubMed ID: 23249404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
